Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ID1 |
| Upstream (Parents) |
|---|
| (<<) BLNK → ID1 |
| (<<) CDKN1A → ID1 |
| (<<) CKB → ID1 |
| (<<) CXCR7 → ID1 |
| (<<) FGF1 → ID1 |
| (<<) FGFR3 → ID1 |
| (<<) HLA-A → ID1 |
| (<<) HMGA2 → ID1 |
| (<<) MAP3K5 → ID1 |
| (<<) NUPR1 → ID1 |
| (<<) PIK3R2 → ID1 |
| (<<) RHOT1 → ID1 |
| Downstream (Children) |
|---|
| ID1 → ARSD (>>) |
| ID1 → CLCA4 (>>) |
| ID1 → FZD9 (>>) |
| ID1 → GALR3 (>>) |
| ID1 → IFITM3 (>>) |
| ID1 → KCNG1 (>>) |
| ID1 → RNF138 (>>) |
| ID1 → SGK1 (>>) |
| ID1 → SMAD7 (>>) |
| ID1 → SPINK1 (>>) |
| ID1 → UST (>>) |
| ID1 → VAV1 (>>) |
| ID1 → ZNF224 (>>) |
